HCPCS Level II code C1762 designates human-derived connective tissue grafts, including fascia lata, used in reconstructive and soft-tissue reinforcement procedures. This code is important nationally because it standardizes billing for a range of biologic graft materials that support surgical repair across multiple specialties, impacting hospital supply, surgical planning, and payer coverage decisions.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage considerations and payer inclusion, typical sites of service, and clinical contexts where C1762 is applied. The publication summarizes payment benchmarks where available, common billing and coding considerations, and potential policy updates affecting graft material reimbursement.

The report supplies clinical context for use of human connective tissue grafts, outlines service settings (hospital OR, ambulatory surgery centers, surgical clinics), and highlights what providers and billing professionals should expect when coding for these grafts. Data not available in the input is noted where applicable.